ARGOS THERAPEUTICS INC - FORM S-1/A - EX-23.1 - CONSENT OF PRICEWATERHOUSECOOPERS LLP - February 16, 2012

Attached files

file filename
S-1/A - AMENDMENT NO. 5 TO FORM S-1 - ARGOS THERAPEUTICS INCd214145ds1a.htm
EX-4.1 - SPECIMEN CERTIFICATE EVIDENCING SHARES OF COMMON STOCK - ARGOS THERAPEUTICS INCd214145dex41.htm
EX-5.1 - OPINION OF WILMER CUTLER PICKERING HALE AND DORR LLP - ARGOS THERAPEUTICS INCd214145dex51.htm
EX-3.1 - THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF THE REGISTRANT - ARGOS THERAPEUTICS INCd214145dex31.htm
EX-1.1 - FORM OF UNDERWRITING AGREEMENT - ARGOS THERAPEUTICS INCd214145dex11.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the use in this Registration Statement on Form S-1/A of Argos Therapeutics, Inc. of our report dated February 10, 2012, except for the effects of the amended articles of incorporation as described in Note 1, as to which the date is February 15, 2012, relating to the financial statements, which appears in such Registration Statement. We also consent to the references to us under the heading “Experts” in such Registration Statement.

/s/ PricewaterhouseCoopers LLP

Raleigh, North Carolina

February 15, 2012

ARGOS THERAPEUTICS INC Reports